Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder

ClinicalTrials.gov ID: NCT07221578

Public ClinicalTrials.gov record NCT07221578. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 10:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Acute Anxiety in Patients With Social Anxiety Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a single oral dose of VQW-765 compared to placebo in adults with social anxiety disorder.

Study identification

NCT ID
NCT07221578
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Vanda Pharmaceuticals
Industry
Enrollment
500 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 22, 2025 (Actual)
Primary completion
Dec 2026 (Estimated)
Completion
Apr 2027 (Estimated)
Last update posted
Aug 17, 2026

2025 – 2027

United States locations

U.S. sites
30
U.S. states
15
U.S. cities
29
Facility City State ZIP Site status
Vanda Investigational Site Phoenix Arizona 85012 —
Vanda Investigational Site Scottsdale Arizona 85260 —
Vanda Investigational Site Encino California 91316 —
Vanda Investigational Site Mission Viejo California 92691 —
Vanda Investigational Site San Diego California 92123 —
Vanda Investigational Site San Jose California 95124 —
Vanda Investigational Site Walnut Creek California 94596 —
Vanda Investigational Site Denver Colorado 80209 —
Vanda Investigational Site Jacksonville Florida 32256 —
Vanda Investigational Site Miami Florida 33125 —
Vanda Investigational Site Orlando Florida 32801 —
Vanda Investigational Site Tampa Florida 33629 —
Vanda Investigational Site Atlanta Georgia 30329 —
Vanda Investigational Site Suwanee Georgia 30024 —
Vanda Investigational Site New Orleans Louisiana 70115 —
Vanda Investigational Site Pikesville Maryland 21208 —
Vanda Investigational Site Rockville Maryland 20852 —
Vanda Investigational Site Towson Maryland 21204 —
Vanda Investigational Site Saint Charles Missouri 63304 —
Vanda Investigational Site St Louis Missouri 63182 —
Vanda Investigational Site Las Vegas Nevada 89102 —
Vanda Investigational Site Princeton New Jersey 08540 —
Vanda Investigational Site Albuquerque New Mexico 87109 —
Vanda Investigational Site New York New York 10016 —
Vanda Investigational Site New York New York 10036 —
Vanda Investigational Site Charlotte North Carolina 28210 —
Vanda Investigational Site Wilmington North Carolina 28403 —
Vanda Investigational Site Houston Texas 77081 —
Vanda Investigational Site Wichita Falls Texas 76309 —
Vanda Investigational Site Orem Utah 84097 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07221578, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 17, 2026 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07221578 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →